Sixteen equities research analysts cover Clorox, assigning five sell ratings, ten hold ratings and one buy rating. These results combine to a consensus recommendation of “reduce,” reflecting a prevailing cautious stance on the company’s near-term prospects.

An overall “reduce” consensus may weigh on investor sentiment and pressure share performance if no positive catalysts emerge. Investors often track consensus ratings for guidance, and a shift toward more sell and hold opinions could influence trading decisions.